Supplement

Question and Answer

Published Online: January 01, 2002
Log in to access PDF
Issue: Symposium Reporter - Lipid Management
SUPPLEMENT CONTENT
Review of Clinical trial Data Reaffirms Safety of Statin Therapy
Antonio M. Gotto, Jr, MD, DPhil
Protective Effects of HDL-C and Need to Raise Low Levels Explored
Daniel J. Rader, MD
Risk Factors Common to Insulin Resistance and Atherosclerosis Explain Why Diabetes is a Cardiovascular Disease
Henry N. Ginsberg, MD
Question and Answer
Lipid-Lowering Therapy Stabilizes Plaque Reduces Events by Limiting Inflammation
Peter Libby, MD
New Cholesterol Guidelines Emphasize Risk Assessment
Scott M. Grundy, MD, PhD
WEBCAST HIGHLIGHTS
Cholesterol Goals Established for Patients with Diabetes and Metabolic Syndrome
Steven M. Haffner, MD
Dyslipidemia of Insulin Resistance Syndrome Explained; Need for Treatment to Reduce Risk Emphasized
Henry N. Ginsberg, MD
Heart Protection Study Finds Simvastatin Reduces Vascular Risk in a Wide Range of High-Risk Patients
Rory Collins, MB, BS
Click for Full Issue
More on AJMC.COM
No Result Found
About Us | Contact Us | Advertise | Terms & Conditions | Press Room | Copyright HCPLive 2006-2013 | Intellisphere, LLC. All Rights Reserved.
Partner Websites: Pharmacy Times | Targeted Therapies | PainLive | HCPLive | ONCLive